~~<i id='5428287FB5'><strike id='5428287FB5'><tt id='5428287FB5'><pre id='5428287FB5'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：knowledge 2025-10-06 11:54:04 Page View：25

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Ukrainian soldiers say they owe lives to US
Next article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

leisure time

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Editas, Vertex strike deal on CRISPR

AdobeForadecade,leadingacademicinstitutesandtheirassociatedcompaniesfoughtabruising,headline-grabbin

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

GOP inquiry over gain

BernardMossCourtesyNIAIDFormorethanhalfacentury,scientistBernardMosshasbeencommandingtheattentionofp